Ambu AS (OTCPK:AMBBY)
$ 15.65 0.2 (1.29%) Market Cap: 4.17 Bil Enterprise Value: 4.16 Bil PE Ratio: 124.21 PB Ratio: 5.05 GF Score: 97/100

Q3 2022 Ambu A/S Earnings Call Transcript

Aug 17, 2021 / 07:30AM GMT
Release Date Price: $33 (+0.21%)
Operator

Ladies and gentlemen, welcome to the Ambu Q3 2020 to 2021 Conference. (Operator Instructions) Today, I am pleased to present CEO, Juan Jose Gonzalez; and CFO, Michael Hojgaard. Please begin your meeting.

Juan Jose Gonzalez;S;CEO;Member of Executive Board
Ambu A

/-&

Thank you, and welcome, everyone, for our quarterly 3 earnings. We are excited to have all of you this morning.

Let me start with key messages for this call. First of all, the transition to single-use endoscopy market continues to accelerate. And over the last 3 months, we saw the safety communication from the FDA in bronchoscopy recommending sterilization of reusable endoscope available and the adoption of single bronchoscopy when treating patients at increased risk of the spreading infection. That's basically increasing the cost of using reusable bronchoscopy, and at the same time, clearly encouraging health care systems, all health care systems to consider single-use bronchoscopy for certain patient profiles. And that will accelerate the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot